STIM Neuronetics Inc

Neuronetics Inc is a commercial stage medical technology company. It is focused on designing, developing and marketing products that improve the quality of life for patients who suffer from psychiatric disorders.

As of 09/30/2022     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Diagnostics & Research
Index country:  USA
Country of incorporation:  USA
IPO date:  06/28/2018
Outstanding shares:  27,022,796
Average volume:  137,351
Market cap:   $78,636,336
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
Sedol:      BFXH9H2
Valuation   (See tab for details)
PE ratio:   -2.52
PB ratio:   1.11
PS ratio:   1.37
Return on equity:   -44.58%
Net income %:   -59.70%

2022 © Stock Market MBA, Inc. Terms of use | Privacy policy